Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer.
Thalgott M, Horn T, Heck MM, Maurer T, Eiber M, Retz M, Autenrieth M, Herkommer K, Krause BJ, Gschwend JE, Treiber U, Kübler HR. Thalgott M, et al. Among authors: treiber u. J Hematol Oncol. 2014 Mar 5;7:20. doi: 10.1186/1756-8722-7-20. J Hematol Oncol. 2014. PMID: 24598155 Free PMC article. Clinical Trial.
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.
Schwarzenböck SM, Eiber M, Kundt G, Retz M, Sakretz M, Kurth J, Treiber U, Nawroth R, Rummeny EJ, Gschwend JE, Schwaiger M, Thalgott M, Krause BJ. Schwarzenböck SM, et al. Among authors: treiber u. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2105-2113. doi: 10.1007/s00259-016-3439-9. Epub 2016 Jun 17. Eur J Nucl Med Mol Imaging. 2016. PMID: 27317482 Clinical Trial.
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.
Bundschuh RA, Wendl CM, Weirich G, Eiber M, Souvatzoglou M, Treiber U, Kübler H, Maurer T, Gschwend JE, Geinitz H, Grosu AL, Ziegler SI, Krause BJ. Bundschuh RA, et al. Among authors: treiber u. Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):824-31. doi: 10.1007/s00259-013-2345-7. Epub 2013 Feb 7. Eur J Nucl Med Mol Imaging. 2013. PMID: 23389430
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.
Krause BJ, Souvatzoglou M, Herrmann K, Weber AW, Schuster T, Buck AK, Nawroth R, Weirich G, Treiber U, Wester HJ, Ziegler SI, Senekowitsch-Schmidtke R, Schwaiger M. Krause BJ, et al. Among authors: treiber u. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1861-8. doi: 10.1007/s00259-010-1493-2. Epub 2010 May 30. Eur J Nucl Med Mol Imaging. 2010. PMID: 20512572
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Souvatzoglou M, Weirich G, Schwarzenboeck S, Maurer T, Schuster T, Bundschuh RA, Eiber M, Herrmann K, Kuebler H, Wester HJ, Hoefler H, Gschwend J, Schwaiger M, Treiber U, Krause BJ. Souvatzoglou M, et al. Among authors: treiber u. Clin Cancer Res. 2011 Jun 1;17(11):3751-9. doi: 10.1158/1078-0432.CCR-10-2093. Epub 2011 Apr 14. Clin Cancer Res. 2011. PMID: 21493868
45 results